GlassScriptPhysician profile
John P Rachoy
NPI 1124138805
$21,123.91
in general payments reported to CMS, 2019-2025
32 companies · $3,229 in 2025
The $3,229 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,551 · 2021: $579 · 2022: $847 · 2023: $2,166 · 2024: $2,218 · 2025: $3,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,911 · Travel and Lodging: $2,702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,910.80 |
| Travel and Lodging | $2,701.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,993.08 | 2019-2025 | |
| Stryker Corporation | $6,119.20 | 2019-2025 | Hoffmann, Augment Injectable, Variax |
| Medwest Associates | $1,742.75 | 2019-2023 | |
| Wright Medical Technology, INC. | $1,432.74 | 2019-2020 | |
| Organogenesis INC. | $920.06 | 2019-2025 | Puraply, Puraply Wound Matrix, Cygnus Dual |
| Smith+Nephew, INC. | $397.23 | 2019-2024 | Panta 2, Regranex, Collagenase Santyl |
| Orthofix Medical, INC. | $366.06 | 2019-2025 | Physio-Stim |
| Kerecis Limited | $322.48 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $320.26 | 2024-2025 | Nuzyra |
| Lightbody Medical Technologies INC | $305.35 | 2024-2025 | |
| Depuy Synthes Sales INC. | $212.34 | 2022-2025 | Motoband, Hammerlock, Na |
| Treace Medical Concepts, INC. | $183.12 | 2024-2025 | |
| Convatec INC. | $141.60 | 2024-2025 | |
| Osteocentric Technologies, INC. | $79.58 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Mimedx Group, INC. | $69.58 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $57.70 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $48.56 | 2020 | |
| Medline Industries LP | $43.94 | 2023 | |
| Bioventus LLC | $43.29 | 2025 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $37.65 | 2024-2025 | Qutenza |
| Kci USA, INC. | $33.54 | 2021-2022 | |
| Hartmann USA, INC. | $32.55 | 2023 | Zetuvit Plus |
| Lifenet Health | $29.75 | 2025 | Theragenesis Wound Matrix |
| Aroa Biosurgery Incorporated | $29.72 | 2019 | |
| Electronic Waveform Lab, INC. | $28.97 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $26.28 | 2023 | Seglentis |
| Ani Pharmaceuticals, INC. | $22.49 | 2025 | Purified Cortrophin Gel |
| Next Science LLC | $21.19 | 2023 | Xperience, Surgx, Blastx |
| Horizon Therapeutics Plc | $18.59 | 2022 | |
| Abbott Laboratories | $16.42 | 2019 | |
| Triad Life Sciences INC. | $14.22 | 2022 | |
| Paragon 28, INC. | $13.62 | 2024 | Ankle Fracture |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rachoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.